Company: PSTV
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-178940
Chunk: 52

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: S-1
Chunk 52
---
 |             | 333-210211 |     |         |  99.4 |     |             | 03/15/2016 |
| 10.17

#  |     | Plus Therapeutics, Inc. 2020 Stock Incentive Plan, as amended and restated.                                                |     |                           | 8-K  |     |             | 001-34375  |     |         |  10.1 |     |             | 05/17/2021 |
| 10.18

#  |     | Form of Notice of Grant and Stock Option Agreement under the 2020 Stock Incentive Plan.                                    |     |                           | 10-K |     |             | 001-34375  |     |         | 10.26 |     |             | 02/24/2022 |
II-7

|         |     |                                                                                                                                                              |     | Incorporated by Reference |      |     |             |           |     |         |        |     |             |            |
| Exhibit 
 Number  |     | Description                                                                                                                                                  |     | Form                      |      |     | File Number |           |     | Exhibit |        |     | Filing Date |            |
| 10.19+  |     | Master Services Agreement, dated January 24, 2021, by and between Piramal Pharma Solutions, Inc. and Plus Therapeutics, Inc.                                 |     |                           | 10-K |     |             | 001-34275 |     |         |  10.24 |     |             | 02/22/2021 |
| 10.20

#  |     | Form of Indemnification Agreement.                                                                                                                           |     |                           | 8-K  |     |             | 001-34375 |     |         |   10.1 |     |             | 02/06/2020 |
| 10.21

#  |     | Form of Agreement for Acceleration and/or Severance.                                                                                                         |     |                           | 10-K |     |             | 001-34375 |     |         | 10.113 |     |             | 03/11/2016 |
| 10.22   |     | Cancer Research Grant Contract, effective August                                                                                                             
 31, 2022, by and between the Cancer Prevention and Research Institute of Texas and Plus Therapeutics, Inc.